More Post from the Author
- Keycafe Expands Executive Leadership with Appointments of Rudi Airisto and Robert Johnston as Company Enters Next Phase of Global Growth
- /C O R R E C T I O N -- Tessitura/
- CoolIT Systems Demonstrates 15kW Coldplate, Extending Single-Phase DLC Roadmap Far Beyond 2030
- EQT sets target fund size for EQT Infrastructure VII at EUR 21 billion
- Web3 Has No Safe AI. DMind AI Just Quantified the Gap -- and KDD 2026 Made It Official.
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- Keycafe Expands Executive Leadership with Appointments of Rudi Airisto and Robert Johnston as Company Enters Next Phase of Global Growth
- /C O R R E C T I O N -- Tessitura/
- CoolIT Systems Demonstrates 15kW Coldplate, Extending Single-Phase DLC Roadmap Far Beyond 2030
- EQT sets target fund size for EQT Infrastructure VII at EUR 21 billion
- Web3 Has No Safe AI. DMind AI Just Quantified the Gap -- and KDD 2026 Made It Official.